Pharmacovigilance and Drug Safety Jobs With H-1B Sponsorship: CROs, Pharma and Entry Roles for OPT Grads

Drug safety roles at CROs, pharma companies and PV vendors can lead to H-1B sponsorship, but the case rests on your duties and degree, and pay-to-be-placed PV firms can cost you more than money.

Yes, there are pharmacovigilance jobs with H-1B sponsorship, and drug safety is a realistic field for international students on OPT. The work sits in three places: large contract research organizations (CROs), the drug safety departments of pharma and biotech companies, and specialist PV service vendors. A common entry point for PharmD, M.Pharm and life-science graduates is a drug safety associate role, and the H-1B case rests on its duties and degree requirement, not its title. Disclosure: F1Jobs sells a job-search service, so we have a stake when this guide evaluates PV "training and placement" firms.

Status as of 2026-11-01. The STEM OPT 180-day automatic extension and the OPT unemployment limits (90 days, 150 with STEM OPT) are in effect. The OPT fee is only proposed. The $100,000 H-1B fee is blocked and not being collected. FY2028 H-1B registration is not announced. Dates are in the table near the end.

Do pharmacovigilance jobs offer H-1B sponsorship?

Pharmacovigilance jobs can come with H-1B sponsorship, but it is decided employer by employer and role by role. CROs, pharma drug safety teams and PV vendors all hire safety staff; whether an entry case-processing seat qualifies depends on how the employer defines its duties and degree requirement. Check each employer's past LCAs for safety titles, and read a silent posting as unknown, not no.

If your interest leans toward submissions and labeling rather than adverse events, our regulatory affairs specialist sponsorship guide covers that neighboring path, and the clinical research coordinator and CRA guide covers site-side trial roles that some PharmD graduates use as a bridge into safety.

What does a drug safety associate actually do?

A drug safety associate processes individual case safety reports: adverse events reported by patients, clinicians, trial sites and the published literature. You triage each case for seriousness and expectedness, code events in MedDRA, write the case narrative, assess causality with a safety physician, and chase follow-up information.

The clock is regulatory. Under FDA's postmarketing rule, 21 CFR 314.80(c)(1)(i), the application holder must report each adverse drug experience that is both serious and unexpected "as soon as possible but no later than 15 calendar days from initial receipt of the information." The same section requires periodic reports at quarterly intervals for three years after approval, then annually, which is where aggregate-report writers and signal-management scientists come in.

One interview detail: FDA's adverse event database page is now titled FDA Adverse Event Monitoring System (AEMS), labeled "Formerly FDA Adverse Event Reporting System (FAERS)", and it confirms that events and medication errors are coded in MedDRA terminology.

For drug safety associate visa sponsorship, these duties matter more than the title: the more your daily work depends on pharmacology and clinical judgment, the stronger the link between your degree and the job.

Is pharmacovigilance a specialty occupation?

It can be, but the title does not decide it. USCIS looks at whether this particular position requires a bachelor's or higher degree in a specific specialty that is directly related to the duties. The regulation, 8 CFR 214.2(h)(4)(ii), is blunt about the line. In its words: "A position is not a specialty occupation if attainment of a general degree, without further specialization, is sufficient to qualify for the position. A position may allow for a range of qualifying degree fields, provided that each of those fields is directly related to the duties of the position." USCIS restates the definition and its four position criteria on its H-1B specialty occupations page.

In our reading of that standard, the case is stronger when the job description requires a degree in pharmacy, pharmacology, a life science or medicine, explains why each accepted field is needed, and lists duties that use that degree: causality and expectedness assessment, medical narratives, aggregate-report sections, signal evaluation. It is weaker when the posting says "any bachelor's degree", when duties read like call-center intake or data entry, or when the description does not match what the team actually does.

Since 2026-08-05, USCIS policy PA-2026-05 lets officers deny a request without first issuing an RFE or NOID when required initial evidence is missing (in effect, and challenged in court), so a thin job description at filing carries more risk than before. Petition strategy belongs to your employer's immigration attorney, not to you or a recruiter.

Can a PharmD graduate work in pharmacovigilance on OPT?

Generally yes. USCIS defines OPT as "temporary employment that is directly related to an F-1 student's major area of study" on its OPT page, and drug safety work draws directly on pharmacy training. Your DSO confirms the fit for your record. Three practical points for PharmD and M.Pharm graduates:

• Your unemployment counter runs from your OPT start date. Study in the States explains that SEVIS counts each day "without employer information" toward the 90-day OPT limit (150 days on STEM OPT, including days used on regular OPT). In our reading, a PV course you pay for is training, not employment, so it does not stop that counter; ask your DSO before reporting any training program as OPT employment.
• A PharmD usually gets no STEM extension. Pharmacy programs are usually coded CIP 51.2001, which is not on the DHS STEM list. One edge case: under 8 CFR 214.2(f)(10)(ii)(C), a STEM extension can rest on an earlier US degree that is on the current list and was conferred within the prior 10 years by an accredited, SEVP-certified school; your DSO decides whether yours qualifies. Our PharmD sponsorship guide covers pharmacy employers more broadly.
• Your Indian degree still matters for H-1B. USCIS accepts a foreign degree equivalent to a US degree for H-1B purposes, so a B.Pharm or M.Pharm usually goes through a credential evaluation. It cannot support STEM OPT, because the qualifying degree must come from an accredited US school.

Is pharmacovigilance work STEM OPT eligible?

STEM OPT turns on your degree, not your job. Your degree's CIP code must be on the DHS STEM Designated Degree Program List, the employer must be enrolled in E-Verify and complete Form I-983, and, in USCIS's words on its STEM OPT page, the training "must be directly related to the previously obtained STEM degree."

The CIP code printed on your I-20 decides this. We checked the pharmacy-adjacent codes against the DHS STEM list itself.

Pharmacy and life-science CIP codes on the DHS STEM list (checked 2026-11-01; list last updated 2024-07-22)

The public-health rows show why the code, not the degree name, decides: an MPH coded Epidemiology (26.1309) qualifies, while one coded Public Health, General (51.2201) does not. If your program sits in a gray zone, read what to do when your CIP code is not on the STEM list and talk to your DSO early; a re-code is a school decision, not yours.

USCIS says you can file the STEM OPT I-765 up to 90 days before your OPT EAD expires and within 60 days of the DSO's recommendation; file on time and USCIS "will automatically extend your employment authorization for 180 days." That extension is in effect as of 2026-11-01, untouched by the 2026-10-14 final rule that ended automatic extensions for certain other EAD renewals. Under 8 CFR 214.2(f)(10)(ii)(C), the I-983 must show how the training relates to your STEM degree, with duties, hours and pay commensurate with the employer's similarly situated US workers, at 20 or more hours a week.

A worked timeline: PharmD vs M.S. Pharmaceutical Sciences

Two graduates finish in May 2026 and both start OPT on 2026-07-01. The dates below are an illustration (our arithmetic); your EAD card and I-20 govern your real dates.

The PharmD column is why your first OPT employer matters so much: one that will not register you in your single season can end your runway on that degree. A cap-exempt employer avoids the lottery, but the cap-gap rule "applies only to beneficiaries of cap-subject H-1B petitions," so the petition timing has to work before your OPT EAD ends; ask the employer's immigration attorney. Some public universities are also off the table for now: Florida paused new H-1B hires at its 12 public universities from 2026-03-02 until at least 2027-01-05, Central Florida Public Media reported, and Texas froze new petitions at state agencies and public universities to 2027-05-31 unless its workforce commission permits one.

How do you check whether a drug safety employer sponsors H-1B?

A certified LCA shows an employer intended to file for a job like yours, not that a petition was filed or approved, so use both sources below. Our step-by-step LCA search guide walks through the files in more detail.

1. Download the latest LCA disclosure file from DOL OFLC's Performance Data page. As of 2026-11-01 it is FY2026 Q3 (determinations from 2025-10-01 to 2026-06-30), with a record layout PDF.
2. Filter the job title column for "drug safety", "pharmacovigilance", "safety scientist", "case processing", "aggregate report" and "signal". Searching "PV" alone also returns solar photovoltaic jobs, so check the SOC title on every hit.
3. Record each hit's employer legal name, SOC code, wage offered, prevailing wage level, worksite and case status. The SOC code shows how that employer classifies the role, and the legal name often differs from the brand name on job boards.
4. Check the H-1B-dependent and willful-violator answers, and whether the worker will be placed with a secondary entity (another company's site).
5. Search the employer's legal name on the USCIS H-1B Employer Data Hub, which says it covers fiscal years 2009 through 2026 (quarter 4). It reports first decisions on initial and continuing petitions by employer, not by job title.
6. Confirm the employer is not on DOL's H-1B Debarred/Disqualified List of Employers. The list is "effective as of October 1, 2026" and names six willful violators: GowraTech, Renotek Group, Seeloz, Sherwood Academy, Da Vinci Academy and Sadup Softech.
7. Look up your SOC code and worksite on the OFLC Wage Search to see which wage level your offer reaches.

Step 6 is a floor, not a clean bill of health: the list catches only employers already found to be willful violators.

How the H-1B lottery treats entry safety roles

Wage-weighted selection has been in effect since 2026-02-27: each registration gets entries by the highest OEWS wage level the offered wage reaches for its occupation and area, from four at Level IV to one at Level I. An entry-level drug safety offer at Level I gets one entry; check where yours lands in step 7 rather than assuming. Under 8 CFR 214.2(h)(8)(iii)(A)(3), USCIS must announce the FY2028 window at least 30 days ahead; watch its registration process page.

Two more items matter if you are weighing a PV vendor. The draft rule "Reforming the H-1B Nonimmigrant Visa Classification Program" (RIN 1615-AD00) has been under OIRA review since 2026-08-24; its agenda abstract mentions "increasing oversight over third party placements", but no text is public. Separately, DOL announced on 2026-10-08 a PERM suspension for eight employers (Microsoft, Adobe, Cognizant, Infosys, TCS, Wipro, HCL and Capgemini); as of 2026-11-01 there is no published notice or stated end date. That affects green-card labor certification, not H-1B: as Mayer Brown notes, the action "does not suspend any employer from the H-1B program."

The PV "training and placement" trap

Our stake again: F1Jobs sells a job-search service. Search for pharmacovigilance jobs on OPT and many results come from firms that sell a PV course bundled with a promise of placement, often pitched to Indian PharmD and M.Pharm graduates. Some courses teach real skills; the risk is in what gets bundled with them. Our explainer on what "training and placement" actually means covers the business model and the paper-employment pattern.

Common misconception: "A PV certificate plus a placement firm's network gets me sponsored." Correction: Sponsorship depends on a real employer filing for a real role that meets the specialty-occupation test. A certificate does not change that test, and no placement firm can promise a lottery result.

Red flags that should stop you before you pay:

• The firm offers to "add" PV experience or a past employer to your resume. Misstated experience can surface in a petition, an I-983 or a later green-card case.
• It offers to list itself as your employer in SEVIS while you train unpaid. That is the paper-employment pattern our explainer describes, and your DSO should hear about the offer before you agree.
• It promises a job, a salary or H-1B sponsorship, charges a placement fee upfront or out of future pay, or cannot name the clients where past trainees work.
• It asks you to pay the company that will also sponsor you. Ask an immigration attorney which petition costs the law requires the employer to bear.

Rules that affect your PV job search (as of November 1, 2026)

The OPT fee proposal would charge the school $70,000 before an initial OPT recommendation and $30,000 before each later one, including STEM OPT, and would reach only DSO recommendations dated 60 or more days after a final rule. Schools could pass the cost on to students. It is not law.

Common mistakes

• Taking the first PV offer without checking its LCA history. On a PharmD's single OPT year, an employer that will not register you can end your US runway.
• Assuming "pharma" means specialty occupation. The duties and degree requirement decide it, and a general-degree posting can sink a petition.
• Confusing your degree with your job for STEM OPT. A PharmD in a drug safety role still has CIP 51.2001, which is not on the STEM list.
• Paying for placement or "experience." Fees do not buy sponsorship, and invented experience follows you into every later filing.
• Reading a PERM suspension as an H-1B ban. The 2026-10-08 action concerns green-card labor certification only.

Frequently asked questions

Do CROs sponsor H-1B for drug safety associates?

Some do, but sponsorship is decided company by company and often role by role, so a CRO that sponsors biostatisticians may not sponsor entry-level case processors. Check the employer's certified LCAs for drug safety and pharmacovigilance titles in DOL's disclosure files (the latest, FY2026 Q3, covers determinations through 2026-06-30) and its record on the USCIS H-1B Employer Data Hub before relying on a recruiter's answer.

Is pharmacovigilance a specialty occupation for H-1B?

It can be, but the title does not decide it. Under 8 CFR 214.2(h)(4)(ii) the position must require a bachelor's or higher degree in a directly related specific specialty, and a role open to any general degree does not qualify. In our reading, medical review, causality assessment and aggregate safety writing that require a pharmacy or life-science degree fit that test better than pure case intake. Your employer's immigration attorney makes the call.

Can a PharmD graduate work in pharmacovigilance on OPT?

Generally yes, because OPT must be directly related to your major and drug safety work draws on pharmacy training; your DSO confirms the fit. A PharmD is usually coded CIP 51.2001, which is not on the DHS STEM list (last updated 2024-07-22), so you typically get 12 months of OPT and one H-1B registration season during it.

Are pharmacovigilance training and placement programs legitimate?

Some PV courses are real education, but a program that charges you for placement, promises a job, offers to add PV experience to your resume or lists itself as your employer while you train unpaid puts your OPT record and future petitions at risk. F1Jobs sells a job-search service, so weigh our view accordingly, and talk to your DSO before signing anything that touches SEVIS.

Is pharmacovigilance work STEM OPT eligible?

STEM OPT eligibility turns on your degree, not the job title. Your CIP code must be on the DHS STEM list (pharmaceutical sciences 51.2010, pharmacology 26.1001 and epidemiology 26.1309 are; pharmacy 51.2001 is not), the employer must use E-Verify and sign Form I-983, and the training must be directly related to that degree. As of 2026-11-01 the 180-day automatic extension for timely STEM OPT filings remains in effect.

Sources

• USCIS, H-1B Specialty Occupations (definition and position criteria)
• USCIS, Optional Practical Training (OPT) for F-1 Students
• USCIS, OPT Extension for STEM Students (STEM OPT)
• ICE SEVP, DHS STEM Designated Degree Program List (last updated 2024-07-22)
• Study in the States, Unemployment Counter
• USCIS, Cap-gap extension of OPT and F-1 status
• DOL OFLC, Performance Data and LCA disclosure files
• DOL WHD, H-1B Debarred/Disqualified List of Employers
• USCIS, H-1B Employer Data Hub
• DOL, OFLC Wage Search
• USCIS, H-1B Electronic Registration Process
• Federal Register, Optional Practical Training Fees (proposed rule)
• Reginfo.gov, RIN 1615-AD00 agenda entry
• Mayer Brown, DOL enforcement actions in H-1B and PERM fraud probe (law-firm analysis)
• Central Florida Public Media, Florida Board of Governors H-1B hiring freeze
• FDA, Adverse Event Monitoring System (AEMS); 21 CFR 314.80 (postmarketing adverse drug experience reporting)

How we checked this: we read the USCIS, ICE, Study in the States, DOL and FDA pages above, the text of 8 CFR 214.2(h)(4)(ii), 8 CFR 214.2(f)(10)(ii)(C) and 21 CFR 314.80 on eCFR, and the DHS STEM list itself, between 2026-11-01 and 2026-11-02.

This is general information, not legal or tax advice. Your own I-20, EAD and notices govern your situation; your DSO is the person for OPT, STEM OPT and SEVIS questions, and a licensed immigration attorney is the person for petitions and status strategy.

If you are on OPT and want a focused search for drug safety employers that actually file for roles like yours, F1Jobs can help you build and work that list.